Moby Strategic Execution and Portfolio Transformation. Management attributes the 2025 performance to a 'focus, execution, and growth ...

Gross Profit -- $18.7 million, representing growth of 20% compared to $15.5 million previously reported. Oxford Collaboration ...

Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial ResultsFourth quarter revenue growth of 19% to $29.5 million2025 revenue growth ...

A Super Bowl ad used NFL tight ends to promote a finger-free prostate cancer screening. The ad, starring players like Rob Gronkowski, played heavily on humor to encourage men to get a PSA blood test.

The Food and Drug Administration recently approved the IsoPSA blood test, which was developed by Cleveland Diagnostics, a Cleveland Clinic Innovations portfolio company, which looks for specific ...

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...

The region’s hub of diagnostics and testing firms saw a slight increase in employment for the first time in four years, signaling a potential return to normal following lingering effects of the ...

IRVINE, CA – January XX, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leading precision diagnostics company, today announced the next major phase of its ...

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer IRVINE, CA – January XX, 2026 (GlobeNewswire) ...